News Focus
News Focus
icon url

theorysuit

09/15/25 8:53 AM

#788248 RE: RRP60 #788246

Did you read his post? There are nothing but truths in there. You are damaging retail investors by trying to suppress the truth about this POS scam company. They are doing a perfectly fine job on their own of diluting the piss out of the company and delivering nothing to shareholders. The trial ended in 2018.......7 years later where are they?
icon url

AllSheWrote

09/15/25 10:27 AM

#788258 RE: RRP60 #788246

Everything in that post is a fact. No one has damaged DCVax more than the people who were charged with proving its efficacy. They failed. Quit tilting at windmills and face the truth. The sooner you do, the better off you will be.
icon url

AllSheWrote

09/15/25 10:28 AM

#788259 RE: RRP60 #788246

Thank you for this fact-by-fact statement of reality. The trial results are scientifically invalid. That is why NWBO did not submit to the FDA, and it's why almost two years have passed since they submitted to MHRA with no approval.
icon url

jondoeuk

09/18/25 1:47 AM

#788767 RE: RRP60 #788246

You can accuse me of causing ''years of damage,'' but all I've done is point out what the data and trial history actually show. The DCVax-L trial and its data are riddled with problems. These aren't ''half-truths'' - they are facts acknowledged by multiple independent experts, including Prof. Stupp, one of the most respected authorities in glioblastoma.

Even if regulatory approval ever comes, it won't erase all the flaws in the trial or prove that DCVax-L is effective. Regulators sometimes approve treatments on (very) limited evidence, often due to unmet need or other considerations. That possibility - however slim - doesn't rewrite history or change the data.